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Breast implant–associated anaplastic large-cell lymphoma (ALCL) is a concerning clinical entity that has been observed in recent years. 
A well-known mode of presentation for ALCL is late 
periprosthetic seroma. We present a case of late se-
roma occurring in the context of implant rupture, 
with no detectable ALCL.
CASE	REPORT
A 69-year-old woman presented in late Decem-
ber 2014 with gross swelling of her reconstructed 
left breast and a maculopapular rash. She had un-
dergone delayed bilateral implant based recon-
struction 2 years previously, after right therapeutic 
and left prophylactic mastectomy. The reconstruc-
tion was performed in 2 stages with textured surface 
tissue expanders (PMT Integra, PMT Corporation, 
Minn.), followed by imprint-textured surface, co-
hesive gel implants (Mentor Contour Profile Gel, 
Mentor Worldwide LLC, Calif.). There were no im-
mediate postoperative complications, and all was 
well at a follow-up appointment 24 months after 
surgery, and follow-up photographs were obtained 
(Fig. 1).
The patient then presented 3 weeks later with 
marked swelling of the reconstructed left breast and 
a maculopapular rash developed around the recon-
structive scar on the same side over the previous week 
(Fig. 2). For the rash, she had previously seen a der-
matologist, who prescribed steroid cream and tab-
lets, with no improvement. Ultrasound and magnetic 
resonance imaging were obtained. Ultrasonography 
revealed a large volume of fluid surrounding the left 
breast implant, and 840 ml of viscous straw-colored 
fluid was aspirated under ultrasound guidance, and 
sent for cytology. Magnetic resonance imaging of the 
reconstructed breast revealed a rupture of the left 
breast implant, with a tear in the silicone rubber shell 
visible on its deep aspect, at the shell patch juncture 
(Fig. 3). There were no systemic signs of infection, 
and the white cell count was normal. However, C-re-
active protein was increased to 120 mg/l.
Surgery was undertaken, and an obvious tear 
was seen at the interface of the smooth and tex-
tured parts of the posterior surface of the implant 
(Fig. 4). The likely cause at that stage was consid-
ered to be implant rupture due to either mechani-
cal forces or a one-off manufacturing fault. As the 
patient had not had any problems with the contra-
lateral identical implant, a new implant of the same 
size and brand was inserted. Postoperatively, there 
was <20 ml of output in the surgical drain across the 
first 12 hours after surgery, and the rash resolved 
Disclosure: The authors have no financial 
 interest to declare in relation to the content of this 
article. The Article Processing Charge was paid for 
by the Department of Plastic and Reconstructive 
Surgery, Flinders University, South Australia.
An Uncommon Presentation of Breast Implant 
Rupture
From the *Department of Plastic and Reconstructive Surgery, 
Flinders Medical Centre, Bedford Park, South Australia, 
Australia; and †Department of Surgery, Flinders University, 
Bedford Park, South Australia, Australia.
Received for publication January 28, 2016; accepted March 
9, 2016.
Copyright © 2016 The Authors. Published by Wolters 
Kluwer Health, Inc. on behalf of The American Society of 
Plastic Surgeons. All rights reserved. This is an open-access 
article distributed under the terms of the Creative Commons 
Attribution-Non Commercial-No Derivatives License 4.0 
(CCBY-NC-ND), where it is permissible to download and 
share the work provided it is properly cited. The work cannot 
be changed in any way or used commercially.
DOI: 10.1097/GOX.0000000000000699
Eugene Koh, MBBS, MSSc*
David I. Watson, MD, FRACS†
Nicola R. Dean, MBChB, 
PhD, FRACS(Plas)*
Koh et al.
Summary: Late periprosthetic seroma has lately been concerning for breast 
implant-associated anaplastic large cell lymphoma. The authors present an 
uncommon presentation of breast implant rupture with a seroma and skin 
rash forming 2 years after insertion of the implant. (Plast Reconstr Surg Glob 




2PRS Global Open • 2016
within days of having the implant replaced. The 
ruptured implant was also returned to the manu-
facturer for testing, which did not reveal any manu-
facturing defects.
Analysis of the seroma fluid revealed an inflam-
matory exudate, and flow cytometry did not reveal 
any evidence of lymphoma or neoplasia. A skin bi-
opsy at that time showed tinea incognito and no neo-
plasia. There were no postoperative complications, 
and 12 months later, there has not been any recur-
rence of the swelling or rash.
DISCUSSION
Our patient developed a late seroma in a recon-
structed breast after rupture of a silicone breast im-
plant. Silicone has long been thought to be an inert 
material, which can be safely be implanted in the hu-
man body. However, in the 1970s and 1980s, there was 
significant focus on the possibility of severe immune 
reactions to silicone gel. Ojo-Amaize et al1 found that 
25% of women with silicone breast implants who were 
experiencing symptoms, such as muscle weakness and 
chronic fatigue, developed abnormal T-cell responses 
to silicone. Narini et al2 found, in animal models, that 
injection of silicone gel induced an antigen-specific 
lymphocyte-mediated response in the animal, thereby 
causing a delayed type hypersensitivity. Dargan et al 
reported a delayed hypersensitivity reaction to a tex-
tured silicone implant within weeks of insertion, in a 
woman who had undergone removal of a prosthesis 3 
years earlier, after wound dehiscence. Capsule biop-
sies demonstrated a large lymphoid cell reaction, con-
sistent with a delayed type hypersensitivity reaction.3 
It is this hypersensitivity reaction that can lead to the 
release of inflammatory mediators like histamine and 
prostaglandins, causing the formation of a seroma.
Late periprosthetic seroma is rare, with 1 series of 
47,028 patients reporting an incidence of 0.13% of se-
roma formation occurring ≥1 year after implantation.4
ALCL is a rare disease; making up only 2% of all 
newly diagnosed non-Hodgkin’s lymphomas world-
wide. Despite that, multiple cases of ALCL develop-
ing next to breast implants have been reported.5 
According to the World Health Organization, it can 
be classified into 2 types: the systemic type, affecting 
lymph nodes and extranodal sites (causing systemic 
symptoms), and the cutaneous type (causing skin le-
sions).6 When a woman presents with a seroma or 
mass >6 months after insertion of a breast implant, 
the possibility of ALCL is of great concern. There 
has been a great deal of focus on ALCL more recent-
ly, but no work looking at possible links with previous 
immune reactions. It may be that understanding the 
broad areas of immune reactions to silicone gel and 
to late seromas in those without ALCL will be helpful 
in expanding the understanding of ALCL itself.
Ruptured breast implants can commonly cause a 
change in the breast shape, lumpiness, localized skin 
redness, tenderness, and sensitivity. Clinical exami-
nation has a reported 30% sensitivity of detecting 
a ruptured breast implant, whereas magnetic reso-
nance imaging has the highest sensitivity at 90%.7,8
There is only 1 other reported case of rash arising 
from a ruptured breast implant; however, this was in-
volving rupture of Poly Implant Prothèse implants 
(Poly Implant Prothèse, France), whose silicone did 
not meet appropriate standards.8
Fig. 2. picture obtained at the time of replacement of the left 
breast implant shows the maculopapular rash around the 
scar of the previous incision.
Fig. 1. Follow-up picture obtained weeks before the onset of 
symptoms.
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CONCLUSIONS
We report an uncommon presentation of breast 
implant rupture, with a skin rash and seroma form-
ing 2 years after insertion of the implant. Although 
silicone has been thought to be inert and safe for im-
plantation into the human body, several studies have 
shown an immune response to silicone in a propor-
tion of patients, even with intact implants. Careful 
evaluation is needed, and given the growing con-
cern of a link between ALCL and breast  implants, 
this must also be considered when surgeons are con-
fronted with such a problem.
Eugene Koh, MBBS, MSSc
Flinders Medical Centre
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Fig. 3. Magnetic resonance imaging showing breach of the envelope at the deep 
aspect of the implant. Multiple areas of water signal content are noted within the 
silicone in the implant.
Fig. 4. arrow indicating 5-cm rupture of the deep surface of 
the implant at the shell patch juncture.
